SCHEDULE 13D/A: ASE Technology Holding Amends Ainos, Inc. Convertible Note, Extends Maturity and Solidifies 17% Stake

Sentiment:

Schedule 13D Amendment


ASE Technology Holding Co., Ltd. and its subsidiary ASE Test, Inc. have amended a 2023 convertible promissory note with Ainos, Inc., extending its maturity to March 2027 and maintaining a significant 17.0% beneficial ownership stake.

Capital raiseThe document details a $2,000,000 commitment from ASE Test Taiwan to Ainos, Inc. under the 2023 Agreement, exchanged for convertible promissory notes.It also outlines a $9,000,000 purchase of a Convertible Note by ASE Test Taiwan from Ainos, Inc. under the 2024 Agreement.These convertible notes represent capital raised by Ainos, Inc. from ASE Test Taiwan.

Summary

  • ASE Technology Holding Co., Ltd. (ASX) and its indirect wholly-owned subsidiary, ASE Test, Inc. (ASE Test Taiwan), collectively the Reporting Persons, beneficially own 3,148,788 shares of Ainos, Inc. common stock, representing 17.0% of the class.
  • This beneficial ownership includes 29,411 directly owned shares, 499,377 shares convertible from a 2023 agreement, 2,120,000 shares convertible from a 2024 agreement, and 500,000 shares from a warrant issued under the 2024 agreement.
  • The 2023 Agreement, originally dated March 13, 2023, involved ASE Test Taiwan committing $2,000,000 to Ainos, Inc. for convertible promissory notes, with funds provided in April and September 2023.
  • On March 10, 2025, the 2023 Agreement was amended, extending the note's maturity to March 12, 2027, and setting a 6% compound interest rate.
  • The conversion price for the amended 2023 note is the lower of $7.50 per share or the higher of the 30-day average closing price or $4.50 per share (resulting in 499,377 shares at $4.50).
  • The 2024 Agreement, dated May 3, 2024, involved ASE Test Taiwan purchasing a $9,000,000 convertible note from Ainos, Inc. at a conversion price of $4.50 per share (2,120,000 shares), also bearing 6% compound interest with a three-year term.
  • As part of the 2024 Agreement, ASE Test Taiwan also received a five-year warrant to purchase 500,000 shares at $4.50 per share, exercisable after six months.
  • A Voting Agreement, effective May 3, 2024, mandates ASE Test Taiwan to vote its Ainos, Inc. shares as determined by Ainos Inc. (Cayman Islands corporation) and restricts ASE Test Taiwan from selling more than 20% of its shares annually without Ainos KY's consent.
  • The purpose of the acquisition is stated as a financial investment, with Reporting Persons potentially engaging in discussions regarding Ainos, Inc.'s business, strategy, and future plans.

Sentiment

Score: 7

Explanation: The sentiment is generally positive for Ainos, Inc. as a significant investor is extending financing terms and maintaining a substantial stake, indicating continued support and potential strategic alignment. While there is dilution risk from conversion, the capital infusion and long-term commitment are beneficial.

Positives

  • The amendment to the 2023 convertible note extends the maturity date to March 12, 2027, providing Ainos, Inc. with longer-term financing.
  • The continued significant investment by ASE Technology Holding and ASE Test Taiwan, maintaining a 17.0% beneficial ownership, demonstrates ongoing financial commitment to Ainos, Inc.
  • The Reporting Persons' stated intent to engage in discussions regarding Ainos, Inc.'s business, strategy, and potential business combinations suggests a proactive and supportive investor role.
  • The 6% compound interest on the convertible notes provides a clear cost of capital for Ainos, Inc. while allowing for potential equity conversion.

Negatives

  • The conversion of the promissory notes and warrants will result in dilution for existing Ainos, Inc. shareholders, as 3,119,377 additional shares could be issued from the convertible instruments and warrant.
  • The Voting Agreement grants Ainos Inc. (Cayman Islands) sole discretion over how ASE Test Taiwan votes its shares, potentially limiting ASE Test Taiwan's independent influence despite its significant stake.
  • Restrictions on ASE Test Taiwan selling more than 20% of its shares annually could limit liquidity for this large shareholder, though unused allocations roll over.

Risks

  • Potential dilution of existing shareholders' equity if the convertible notes and warrants are fully converted, increasing the total number of outstanding shares.
  • Fluctuations in Ainos, Inc.'s stock price could impact the effective conversion price of the 2023 note, as it is tied to the lower of $7.50 or the higher of the 30-day average closing price or $4.50.
  • The Reporting Persons' investment strategy may change, potentially leading to future sales of shares or changes in their engagement with Ainos, Inc.'s management and board.
  • The Voting Agreement's terms could limit ASE Test Taiwan's ability to act independently in shareholder votes, potentially impacting corporate governance dynamics.

Future Outlook

The Reporting Persons intend to review their investment in Ainos, Inc. on a continuing basis and may engage in discussions with management and the board concerning the Issuer's business, assets, capitalization, financial condition, operations, management, strategy, potential business combinations, strategic alternatives, and future plans. They may also consider and propose actions to protect or enhance stockholder value, including potentially purchasing additional shares, selling existing shares, or engaging in hedging transactions, depending on various market and company-specific factors.

Industry Context

ASE Technology Holding Co., Ltd. and ASE Test, Inc. are major players in the semiconductor industry, specializing in packaging, testing, and electronic manufacturing services. Their continued investment in Ainos, Inc. suggests a strategic interest in Ainos's business, potentially indicating a belief in Ainos's long-term prospects within or related to the broader technology and semiconductor ecosystem. This investment could provide Ainos with valuable industry expertise and connections.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Voting AgreementASE Test Taiwan entered into a Voting Agreement with Ainos Inc., a Cayman Islands corporation (Ainos KY), effective May 3, 2024. Under this agreement, ASE Test Taiwan has agreed to vote all its current or future acquired voting stock of Ainos, Inc. in the manner determined by Ainos KY in its sole discretion.2024-05-03This agreement centralizes voting control of ASE Test Taiwan's significant stake with Ainos KY, potentially streamlining decision-making but also limiting ASE Test Taiwan's independent influence on corporate governance matters despite its large ownership percentage. It also includes transfer restrictions on ASE Test Taiwan's shares.

Related Party Transactions

  • The investment by ASE Test Taiwan in Ainos, Inc. through convertible promissory notes and warrants, totaling $11,000,000 in principal commitments, constitutes a related party transaction given ASE Technology Holding's significant beneficial ownership (17.0%) in Ainos, Inc.
  • The Voting Agreement between Ainos Inc. (Cayman Islands) and ASE Test Taiwan is also a related party arrangement, governing the voting of ASE Test Taiwan's shares in Ainos, Inc.

Stakeholder Impact

  • Shareholders: Potential dilution from the conversion of notes and warrants, but also benefit from continued capital infusion and strategic support from a major industry player. The Voting Agreement may centralize control.
  • Employees: Continued investment and strategic discussions could imply stability and potential growth opportunities for the company, indirectly benefiting employees.
  • Creditors: The extension of the 2023 note's maturity date provides Ainos, Inc. with more time to manage its debt obligations, which could be viewed positively by creditors.
  • Management: The Reporting Persons' intent to engage in discussions with management and the board suggests a collaborative relationship, but also potential oversight and influence on strategic direction.

Next Steps

  • The Reporting Persons will continue to review their investment in Ainos, Inc. on an ongoing basis.
  • They may engage in discussions with Ainos, Inc.'s management and board regarding business, strategy, and future plans.
  • The Reporting Persons may consider purchasing additional shares, selling existing shares, or engaging in hedging transactions based on market conditions and Ainos, Inc.'s performance.
  • The Voting Agreement will automatically renew for additional one-year periods after May 3, 2025, unless ASE Test Taiwan provides prior notice of termination.

Key Dates

DateDescription
2023-03-13Original date of the Convertible Promissory Note Purchase Agreement (2023 Agreement) between Ainos, Inc. and ASE Test Taiwan.
2023-04-12ASE Test Taiwan provided $1,500,000 of the committed funds under the 2023 Agreement.
2023-09-12ASE Test Taiwan provided the remaining $500,000 of the committed funds under the 2023 Agreement.
2024-05-03Date ASE Test Taiwan entered into the Convertible Note and Warrant Purchase Agreement (2024 Agreement) with Ainos, Inc. and the effective date of the Voting Agreement between Ainos KY and ASE Test Taiwan.
2025-03-07Date as of which Ainos, Inc. reported 15,433,257 shares of common stock outstanding in its annual report on Form 10-K.
2025-03-10Date of the 2023 Agreement Amendment, which modified the term and conversion price of the 2023 Agreement.
2025-03-12Date of filing of this Schedule 13D Amendment.
2025-05-03Initial termination date of the Voting Agreement, after which it automatically renews for additional one-year periods unless terminated.
2027-03-12New maturity date for the convertible promissory note under the amended 2023 Agreement.

Keywords

Ainos Inc., ASE Technology Holding, ASE Test Taiwan, Schedule 13D, Convertible Promissory Note, Warrant, Beneficial Ownership, Semiconductor, Financial Investment, Dilution, Corporate Governance, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.